Mr. Philippe Dubuc reports

THERATECHNOLOGIES ANNOUNCES THE RESIGNATION OF ONE OF ITS DIRECTORS, MR. ALAIN TRUDEAU

Theratechnologies Inc.'s Alain Trudeau has resigned from the board of directors of Theratechnologies and as a member of its audit committee, effective immediately.

"I want to thank Alain for his contributions to Theratechnologies as a director since joining the company in October, 2020, and for completing the annual review for the 2023 fiscal year," said Dawn Svoronos, chair of the board at Theratechnologies. "Alain was the current chair of the audit committee and, during his tenure as a board member, he was also a member of the compensation committee from May, 2021, until March, 2023."

Consistent with past practices, the board of directors of the company will assess whether it will appoint a new member to fill this vacancy at the board before the next annual meeting of shareholders.

The board has appointed Frank Holler as chair of the audit committee and plans to appoint a new independent director to this committee in order to ensure compliance with securities regulation.

About Theratechnologies Inc.

Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.

We seek Safe Harbor.